Home > Healthcare > Medical Devices > Diagnostic Devices > Liver Disease Diagnostics Market

Liver Disease Diagnostics Market Share

Report ID: GMI7939
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Liver Disease Diagnostics Market Share

The liver disease diagnostics industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced diagnostic kits based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, BioMerieux SA, Bio-Rad Laboratories Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., among others have a notable presence in the market.

Liver Disease Diagnostics Market Companies

Some of the eminent market participants operating in the liver disease diagnostics industry include:

Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories Inc.
Cosara Diagnostics Pvt Ltd.
F. Hoffmann-La Roche Ltd.
HORIBA Medical
Laboratory Corporation of America Holdings
Meril Life Sciences Pvt. Ltd.
Qiagen N.V.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for liver disease diagnostics was valued at around USD 39.5 billion in 2023 and is estimated to reach over USD 74.6 billion by 2032 owing to the increasing prevalence of liver diseases, growing awareness regarding liver related complications and the importance of early diagnosis.

The laboratory tests segment of market accounted for over 38.1% share in 2023 and is anticipated to witness notable growth through 2032 as these tests are commonly prescribed in various clinical settings to screen for liver diseases.

North America market accounted for USD 16.2 billion in 2023 and is estimated to witness substantial market growth over 2024 and 2032 due to the obesity pandemic prevalent in the region.

Abbott Laboratories, BioMerieux SA, Bio-Rad Laboratories Inc., Cosara Diagnostics Pvt Ltd., F. Hoffmann-La Roche Ltd., HORIBA Medical, Laboratory Corporation of America Holdings, Meril Life Sciences Pvt. Ltd., Qiagen N.V., Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.